These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4711 related articles for article (PubMed ID: 6546203)

  • 21. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
    Gold JE; Osband ME
    Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.
    Johnson RK; Houchens DP; Gaston MR; Goldin A
    Cancer Chemother Rep; 1975; 59(4):697-705. PubMed ID: 1175164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiolabelling of Corynebacterium parvum and its distribution in mice.
    Sadler TE; Cramp WA; Castro JE
    Br J Cancer; 1977 Mar; 35(3):357-68. PubMed ID: 851511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of growth and metastases of lung carcinoma in C57BL/6 mice by Corynebacterium parvum and its antitumor mechanism].
    Xiao Y; Lu Y; Zhang J; Cao J; Huang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(3):318-21. PubMed ID: 2093073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure to boost the increased clearance of embolic tumor cells from the lung with dose scheduling: Corynebacterium parvum studies.
    Proctor JW; Yamamura Y
    Oncology; 1986; 43(3):192-7. PubMed ID: 3703464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
    Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
    Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma.
    Lipton A; Harvey HA; Balch CM; Antle CE; Heckard R; Bartolucci AA
    J Clin Oncol; 1991 Jul; 9(7):1151-6. PubMed ID: 2045856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in the metastatic mode of B16 malignant melanoma in C57BL/6 mice with ageing and sex.
    Hirayama R; Hirokawa K; Makinodan T
    IARC Sci Publ; 1985; (58):85-96. PubMed ID: 3830885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fat composition of a mouse diet modifies the effects of levamisol on growth and spread of a murine tumor.
    Boeryd B; Hallgren B
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):99-103. PubMed ID: 3984740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized study of Corynebacterium parvum adjuvant therapy following surgery for (stage II) malignant melanoma.
    Thatcher N; Mene A; Banerjee SS; Craig P; Gleave N; Orton C
    Br J Surg; 1986 Feb; 73(2):111-5. PubMed ID: 3512025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune adjuvant therapy in lung cancer.
    Holmes EC
    Prog Exp Tumor Res; 1980; 25():229-41. PubMed ID: 6986634
    [No Abstract]   [Full Text] [Related]  

  • 33. Corynebacterium parvum, but not BCG, induces elevations in plasma proteinase activity similar to those observed in tumor-bearing mice.
    Hart DA
    Haemostasis; 1987; 17(1-2):79-88. PubMed ID: 3297943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effect of viral paramunity inducers PIND-AVI and PIND-ORF with that of BCG, Corynebacterium parvum and levamisole on the growth of radiation-induced murine osteosarcoma.
    Müller-Brunecker G; Erfle V; Mayr A
    Zentralbl Veterinarmed B; 1986 Apr; 33(3):188-95. PubMed ID: 3463079
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Combined surgery and Corynebacterium parvum for treatment of metastasizing tumour in mice.
    Castro JE; Sadler TE
    Br J Surg; 1975 Feb; 62(2):156. PubMed ID: 1115892
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
    Hanna N
    Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of resistant pulmonary tuberculosis using chemotherapy and immunomodulators].
    Olmedo Zenteno C; López Aja J; Rojas García O; Salazar Riverol H; Yarce Palacios E
    Salud Publica Mex; 1983; 25(2):151-9. PubMed ID: 6879325
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
    Dimitrov NV; Denny TN; Weisman MF; Cameron DG
    J Natl Cancer Inst; 1979 Aug; 63(2):423-6. PubMed ID: 379400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum.
    Mak NK; Schiltknecht E; Ada GL
    Cell Immunol; 1983 Jun; 78(2):314-25. PubMed ID: 6861206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of trehalose dimycolate (TDM) and its stereoisometric derivatives, trehalose dicorynomycolates (TDCMs), with low toxicity on lung metastasis of tumour cells in mice.
    Watanabe R; Yoo YC; Hata K; Mitobe M; Koike Y; Nishizawa M; Garcia DM; Nobuchi Y; Imagawa H; Yamada H; Azuma I
    Vaccine; 1999 Mar; 17(11-12):1484-92. PubMed ID: 10195785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 236.